Key Points
- Integer VP Tommy Thomas sold 825 shares on March 13 at an average price of $85, reducing his stake by 15.85% to 4,381 shares valued at $372,385 (SEC filing).
- Integer beat quarterly estimates, reporting $1.76 EPS vs. a $1.70 consensus and $472.06M revenue (up 5% YoY), and set FY2026 guidance of 6.290–6.780 EPS; analysts on average rate the stock a "Hold" with a $102 price target.
- Institutional ownership is very high (99.29%)
Integer Holdings Corporation (NYSE:ITGR - Get Free Report) VP Tommy Thomas sold 825 shares of the stock in a transaction on Friday, March 13th. The shares were sold at an average price of $85.00, for a total value of $70,125.00. Following the completion of the sale, the vice president owned 4,381 shares of the company's stock, valued at $372,385. The trade was a 15.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
Integer Stock Performance
Shares of ITGR stock opened at $87.17 on Wednesday. The company has a market capitalization of $3.00 billion, a price-to-earnings ratio of 30.37, a P/E/G ratio of 1.43 and a beta of 0.75. Integer Holdings Corporation has a 1-year low of $62.00 and a 1-year high of $127.56. The company has a current ratio of 3.32, a quick ratio of 2.23 and a debt-to-equity ratio of 0.69. The stock's fifty day simple moving average is $85.44 and its 200-day simple moving average is $85.38.
Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings data on Thursday, February 19th. The medical equipment provider reported $1.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.70 by $0.06. The firm had revenue of $472.06 million during the quarter, compared to the consensus estimate of $462.73 million. Integer had a return on equity of 13.26% and a net margin of 5.55%.The business's revenue for the quarter was up 5.0% on a year-over-year basis. During the same period in the prior year, the business earned $1.43 EPS. Integer has set its FY 2026 guidance at 6.290-6.780 EPS. On average, sell-side analysts predict that Integer Holdings Corporation will post 6.01 earnings per share for the current fiscal year.
Analysts Set New Price Targets
ITGR has been the subject of a number of research analyst reports. Weiss Ratings upgraded shares of Integer from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Tuesday, February 24th. Raymond James Financial reaffirmed an "outperform" rating and issued a $101.00 price target on shares of Integer in a research note on Monday, February 23rd. Wells Fargo & Company increased their price objective on Integer from $72.00 to $84.00 and gave the stock an "equal weight" rating in a report on Friday, February 20th. Truist Financial lifted their price objective on Integer from $95.00 to $97.00 and gave the company a "buy" rating in a research report on Friday, February 20th. Finally, Citigroup boosted their target price on Integer from $75.00 to $92.00 and gave the company a "neutral" rating in a research note on Friday, February 20th. Four equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, Integer currently has an average rating of "Hold" and an average price target of $102.00.
Get Our Latest Stock Report on ITGR
Institutional Investors Weigh In On Integer
Several institutional investors and hedge funds have recently added to or reduced their stakes in ITGR. Corient Private Wealth LLC bought a new stake in Integer during the fourth quarter worth approximately $539,000. T. Rowe Price Investment Management Inc. raised its position in shares of Integer by 800,382.9% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 280,169 shares of the medical equipment provider's stock valued at $21,974,000 after purchasing an additional 280,134 shares during the period. Mercer Global Advisors Inc. ADV raised its position in shares of Integer by 1.4% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 41,049 shares of the medical equipment provider's stock valued at $3,219,000 after purchasing an additional 555 shares during the period. XTX Topco Ltd acquired a new stake in shares of Integer in the fourth quarter worth $4,581,000. Finally, Voloridge Investment Management LLC bought a new stake in shares of Integer during the 4th quarter worth $14,694,000. 99.29% of the stock is currently owned by institutional investors and hedge funds.
Integer Company Profile
(
Get Free Report)
Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.
Integer's product portfolio is organized into two core segments: Advanced Delivery and MedTech.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
